About the Book: The Ozempic Revolution
The newest class of weight loss drugs (GLP-1s) are complete game-changers in
their potential to reverse obesity and its related diseases, with nearly 50% of
Americans qualifying for the use of these drugs. Already 1 in 8 Americans say
theyve tried a GLP-1 medication—but with many acquiring their prescription from
online pharmacies, med spas, and general practitioners, they face a huge gap
between trying the drug and achieving their health goals with it long-term.
Thats where The Ozempic Revolution comes in. Dr. Alexandra Sowa, a leading
obesity medicine specialist, will share her expertise on this much-discussed but
largely misunderstood class